Key facts for DRG 016
- FY2027 relative weight
- 6.0162
- Higher than 94% of all MS-DRGs
- Change vs FY2026
- +1.5%
- FY2026 weight 5.9297
- Geometric mean LOS
- 15.6 days
- Arithmetic mean 17.1 days
- MDC
- Pre-MDC
- Pre-MDC (transplants, tracheostomy, ECMO)
- Severity level
- with CC (complication or comorbidity)
- National unadjusted operating payment
- $41,198.94
- Weight × $6,848.00 FY2027 standardized amount; capital adds $3,248.45
- Transfer policy
- Not a transfer DRG
TL;DR
MS-DRG 016 is a medical group in the Pre-MDC set (transplants, tracheostomy and ECMO), at the higher of two severity levels (a CC or an MCC is present). CMS assigns it a FY2027 relative weight of 6.0162 with a geometric mean length of stay of 15.6 days and an arithmetic mean of 17.1. Its weight moved up 1.5% from FY2026 (5.9297). That weight is higher than 94% of all MS-DRGs. Its weight sits 23.1% above DRG 017 (without CC/MCC, 4.8891). The v44 Definitions Manual assigns it through 21 bone marrow transplant (non-operating room procedures) codes.
What changed from FY2026 to FY2027
CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 016 the FY2027 relative weight is 6.0162 against 5.9297 in FY2026, a rise of 1.46%.
| Metric | FY2026 | FY2027 | Change |
|---|---|---|---|
| Relative weight | 5.9297 | 6.0162 | +0.0865 |
| Geometric mean LOS (days) | 16.1 | 15.6 | -0.5 |
| Arithmetic mean LOS (days) | 17.2 | 17.1 | -0.1 |
CC and MCC family
DRG 016 shares its base definition with 1 other MS-DRG split by severity. The family's weights span 4.8891 to 6.0162, a 1.23× spread, which is the payment effect of documenting qualifying complications and comorbidities.
| DRG | Title | FY2027 weight | GMLOS | National operating payment |
|---|---|---|---|---|
| 016 | Autologous Bone Marrow Transplant with CC/MCC | 6.0162 | 15.6 | $41,198.94 |
| 017 | Autologous Bone Marrow Transplant without CC/MCC | 4.8891 | 9.5 | $33,480.56 |
At the national rate, documenting the family's top severity level (DRG 016, $41,198.94) instead of its base level (DRG 017, $33,480.56) changes the operating payment by $7,718.38, the amount at stake when a reviewer removes the MCC or CC that put the stay here. The figures are national operating amounts before the hospital-specific adjustments described below.
National unadjusted payment for DRG 016
Multiplying the FY2027 relative weight (6.0162) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. Across the CC/MCC family the operating amount spans $7,718.38.
| Component | National rate | DRG 016 |
|---|---|---|
| Operating (labor and nonlabor share) | $4,519.68 + $2,328.32 = $6,848.00 | $41,198.94 |
| Capital (federal rate) | $539.95 | $3,248.45 |
| Operating plus capital | $44,447.39 |
These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 016.
Grouper logic (v44 Definitions Manual)
The manual's split table for Autologous Bone Marrow Transplant gives one row per combination of criteria and the MS-DRG it assigns. DRG 016 is the row where Bone Marrow Transplant is Yes, CC or MCC is Yes.
| Bone Marrow Transplant | CC or MCC | DRG |
|---|---|---|
| Yes | Yes | 016 |
| Yes | No | 017 |
Bone Marrow Transplant (Non-Operating Room Procedures): 21 ICD-10-PCS codes in this DRG's assignment logic; the first 12 are shown.
| ICD-10-PCS code | Description |
|---|---|
| 30233C0 | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach |
| 30233G0 | Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach |
| 30233X0 | Transfusion of Autologous Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach |
| 30233Y0 | Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach |
| 30243C0 | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach |
| 30243G0 | Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach |
| 30243X0 | Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach |
| 30243Y0 | Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach |
| XW1337A | Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW133B8 | Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
| XW133G8 | Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
| XW133H9 | Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9 |
Code editor, HAC and CC/MCC exclusion notes for DRG 016
Because this family splits by CC and MCC, a secondary diagnosis on the hospital-acquired condition list that is reported with a present-on-admission indicator of N or U does not count toward the severity level, and a CC or MCC excluded by the principal diagnosis does not count either. Check a secondary diagnosis and its CC exclusion before relying on it for the higher member.
The Definitions Manual lists the diagnosis and procedure codes that lead to DRG 016; these are the ones that are also on a Medicare Code Editor list and can draw that edit.
| MCE edit | List | Codes | Examples |
|---|---|---|---|
| Edit 11 | autologous marrow or stem cell transfusion: non-covered with a listed leukemia | 4 | 30233G0, 30233Y0, 30243G0 |
Documentation and denial exposure
As a medical DRG, assignment depends on the principal diagnosis sequenced from the attending's documentation; a secondary condition sequenced first, or a symptom code in place of the confirmed diagnosis, changes the MDC or the DRG. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).
For teams evaluating QuickIntell software
Evaluate a documentation and coding workflow for DRG 016
Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions — DRG 016
What is MS-DRG 016?
MS-DRG 016 is "Autologous Bone Marrow Transplant with CC/MCC", a medical Medicare Severity Diagnosis-Related Group in the Pre-MDC set (transplants, tracheostomy and ECMO). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.
What is the FY2027 relative weight for DRG 016?
The FY2027 relative weight is 6.0162 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 5.9297, a change of +1.5%.
What is the Medicare base payment for MS-DRG 016?
$41,198.94 for operating costs plus $3,248.45 for capital, $44,447.39 together, at the FY2027 national rates: weight 6.0162 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). DRG 017 (without CC/MCC) comes to $33,480.56 operating on the same basis. The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.
What is the average length of stay for DRG 016?
CMS reports a geometric mean length of stay of 15.6 days and an arithmetic mean of 17.1 days for FY2027. The geometric mean is used for transfer-payment calculations.
Which DRGs are in the same CC/MCC family as 016?
DRG 017 (without CC/MCC, weight 4.8891, GMLOS 9.5 days). Together with DRG 016 the family spans 4.8891 to 6.0162, a 1.23x spread, so documented complications and comorbidities change payment materially.
What documentation supports the severity level of DRG 016?
DRG 016 is the upper level of a two-way split: the stay needs at least one secondary diagnosis on either the CMS CC list or the MCC list that is not excluded for this principal diagnosis. A CC and an MCC pay the same here, so the audit question is only whether one qualifying condition is documented by the treating clinician and shown to be monitored, evaluated or treated; a problem-list entry without assessment is the usual reason the stay drops to the base DRG.
Which codes group to DRG 016?
The v44 Definitions Manual lists 21 bone marrow transplant (non-operating room procedures) codes for this group. Examples from the bone marrow transplant (non-operating room procedures) list, 30243C0 (Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach); 30243G0 (Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach); 30243X0 (Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach); 30243Y0 (Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach).
Is DRG 016 a post-acute transfer DRG?
No. DRG 016 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- IPPS FY2027 Table 5 as corrected by correction notice CMS-1849-CN3Version v44 FY2027 (final rule + CN3) · effective 2026-10-01 · file CMS-1849-CN Table 5.txtSHA-256 2cc4e0b083e62e40…
- IPPS FY2026 Final Rule Table 5 (CMS-1833-F)Version v43 FY2026 · effective 2025-10-01 · file CMS-1833-F Table 5.txtSHA-256 bf8c390d14b3cd3e…
- ICD-10 MS-DRG Definitions Manual v44 (text)Version v44 · effective 2026-10-01 · file fy2027-fr-icd10-ms-drg-definitions-manual-files-v44.zipSHA-256 ae4f6c11727fe91f…
Disclaimer
This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.